Clinical indicators for distinguishing septic arthritis from paediatric transient synovitis of the hip: a systematic review and meta-analysis Authors: Tang QingSong, Miao XinLing, Ren Xiang, Zhao Kang, Hu Jie Published: 2024 ABSTRACT BackgroundSeptic arthritis (SA) of the hip joint is a serious infection that can result in irreversible complications. Distinguishing septic arthritis from transient synovitis, the most common cause of hip pain in children, is crucial for preventing severe outcomes. Existing research has primarily focused on identifying clinical signs and laboratory findings that indicate high-risk patients who may need invasive diagnostic procedures; however, results have been inconsistent. This study aims to evaluate the correlation of various clinical indicators in differentiating septic arthritis from pediatric transient synovitis of the hip.MethodsThis study followed the PRISMA guidelines rigorously and was registered with PROSPERO. We conducted a systematic search of PubMed, Embase, and Cochrane Library databases for relevant literature up to September 2024. Studies included in the analysis were required to evaluate the predictive value of clinical indicators distinguishing septic arthritis and transient synovitis of the hip in children under 18 years of age. The risk of bias and quality of the included studies were assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) and RevMan 5.3. Data synthesis was performed using Stata MP-64 18.0 software to facilitate meta-analysis.ResultsA total of eleven studies were ultimately included for the final analysis, comprising 1810 cases. The results of meta-analysis revealed that history of fever emerged as a significant risk factor for differentiating septic arthritis from pediatric transient synovitis of the hip (OR = 6.04, 95% CI = 2.44–14.97, P < 0.001). Other notable risk factors included non-weight-bearing status (OR = 5.23, 95% CI = 1.38–19.75, P = 0.015), erythrocyte sedimentation rate (OR = 3.98, 95% CI = 1.29–12.30, P = 0.017), and serum white blood cell count (OR = 2.73, 95% CI = 1.23–6.03, P = 0.013). In contrast, C-reactive protein was not a significant risk factor (OR = 7.12, 95% CI = 0.59–85.70, P = 0.122).ConclusionThe clinical indicators involving a history of fever, non-weight-bearing status, erythrocyte sedimentation rate, and serum white blood cell count have been identified as cost-effective routine tests with potential value in differentiating septic arthritis from pediatric transient synovitis of the hip. To enhance the reliability of these findings, further prospective studies are essential.Clinical trial numberNot applicable. Introduction Transient synovitis of the hip (TSH) is a common and benign condition in children, with an estimated annual incidence of about 0.2% and a cumulative risk of experiencing at least one episode reaching 3% [1]. This condition typically resolves on its own without leading to long-term joint harm. Nevertheless, it is vital to differentiate transient synovitis from alternative causes of hip inflammation, particularly septic arthritis (SA), as septic arthritis requires prompt antibiotic treatment and possibly surgical intervention [2]. Accurate differentiation relies on comprehensive patient history, clinical evaluation, laboratory examinations, and imaging studies. A delayed diagnosis of septic arthritis can lead to serious complications such as osteonecrosis of the capital femoral epiphysis, osteomyelitis, chondrolysis, systemic sepsis, and hip joint osteoarthritis [3, 4]. Therefore, recognizing septic arthritis in contrast to transient synovitis in a timely manner is crucial for effective management. Although their clinical manifestations are similar, reliable predictive indicators that can effectively distinguish transient synovitis from septic arthritis remain inadequate. Previous studies have mainly sought to identify clinical signs and laboratory results that signify high-risk patients, who may need invasive diagnostic interventions or treatments. In 1999, Kocher et al. [5] developed a retrospective algorithm identifying four key clinical indicators: history of fever (≥ 38.5 °C), inability to bear weight even with assistance, serum white blood cell count (WBC) exceeding 12 × 109/L, and erythrocyte sedimentation rate (ESR) of 40 mm/hr or more. Caird et al. [6] subsequently introduced an elevated C-reactive protein (CRP) level (≥ 20 mg/L) as an additional predictor. However, research has yielded inconsistent findings regarding these predictors. For example, Luhmann et al. [7] determined that only a temperature above 38.5 °C and serum white blood cell count > 12 × 109/L were effective in differentiating septic arthritis from transient synovitis. Conversely, Caird et al. [6] identified erythrocyte sedimentation rate and C-reactive protein as the sole significant predictors, while Singhal et al. [8] emphasized the significance of C-reactive protein levels and weight-bearing capabilities. In light of these discrepancies, this study aims to assess the relationships between various clinical indicators—history of fever, erythrocyte sedimentation rate, serum white blood cell count, C-reactive protein, and non-weight-bearing status—and their efficacy in distinguishing septic arthritis from pediatric transient synovitis of the hip. To our knowledge, this represents the first meta-analysis that synthesizes existing data to investigate these associations within the literature. Methods Research design and method This investigation represents a diagnostic systematic review and meta-analysis performed following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) standards [9]. Ethical approval and informed consent were deemed unnecessary since all information was derived from existing publications. Additionally, the research protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) before the commencement of data extraction (Registration CRD42024578420). Data source and selection process An extensive literature search was carried out in September 2024 across three principal databases: PubMed, Embase, and The Cochrane Library. The search strategy utilized a mixture of Medical Subject Headings (MeSH) and specific keywords focusing on terms such as “hip transient synovitis”, “hip coxitis fugax”, “irritable hip” and “hip septic arthritis” in conjunction with terms including “child”, “infant”, “newborn” or “pediatric”. To guarantee comprehensive coverage, further pertinent studies were uncovered through careful examination of the reference lists from the chosen articles. Eligibility criteria and study selection This systematic review encompassed studies that fulfilled the following conditions: (1) the aim was to evaluate the predictive significance of clinical indicators differentiating septic arthritis from transient synovitis of the hip in individuals below 18 years of age; (2) the diagnosis of septic arthritis was validated through joint fluid and blood cultures, Gram staining, and analysis of the white blood cell count in hip aspirates. Alternatively, a positive culture from tissue or fluid samples obtained during surgical procedures was also used for confirmation; (3) clinical indicators included (history of fever, erythrocyte sedimentation rate, serum white blood cell count, C-reactive protein, non-weight-bearing status); (4) at least 10 participants were involved; and (5) the study was published in English. Exclusions included reviews, commentaries, case reports, studies involving animal subjects, as well as letters to the editor, conference abstracts, books, editorials, and notes. Methods for data extraction and quality assessment Two independent researchers gathered pertinent data from the chosen studies. The collected information encompassed: first author, publication year, study design, sample size, number of septic arthritis (SA) and transient synovitis (TSH) cases, clinical indicators (such as history of fever, non-weight-bearing status, erythrocyte sedimentation rate, serum white blood cell count, and C-reactive protein), along with the corresponding Adjusted Odds Ratios and 95% confidence intervals (CI). All search outcomes were compiled and independently evaluated for eligibility by two authors. In instances of disagreement, a third author mediated discussions to resolve discrepancies. The screening methodology entailed a thorough examination of abstracts. Following the initial screening and elimination of duplicates, potentially relevant studies underwent an exhaustive full-text review to assess their appropriateness for inclusion. The potential for bias and the quality of the included studies were evaluated utilizing the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool [10]. Discrepancies were addressed through discussion. The quality evaluations concentrated on applicability concerns and risk of bias, resulting in a summary chart designed to analyze the overall bias risk using Review Manager 5.3. Data synthesis and analysis All statistical analyses were performed using Stata MP-64 version 18.0 software, which produced forest plots to encapsulate the results of the meta-analysis. The target effect size was defined as the Adjusted Odds Ratio with a 95% confidence interval (OR, 95% CI). Cochran’s Q test and inconsistency index (I²) were employed to investigate the heterogeneity present among the included studies. The I² statistic was used to evaluate the degree of statistical heterogeneity across the studies, categorized such that values below 50% indicated minimal to moderate heterogeneity, while values above 50% signified substantial heterogeneity. Random effects models were implemented for all quantitative analyses. Deeks’ funnel plot was utilized to evaluate potential publication bias. Throughout our statistical analyses, we maintained a P-value threshold of 0.05 to establish statistical significance. Outcomes Identifcation of relevant studies Our search strategy initially identified 278 articles. Following the elimination of 92 duplicates, we conducted an evaluation of the titles and abstracts of the remaining records, which led to the exclusion of 165 studies—105 based on title assessment and 60 based on abstract examination—due to their failure to meet our inclusion criteria. As a result, the full texts of 21 publications were retained for thorough evaluation, ultimately resulting in the inclusion of eleven studies in our systematic review and meta-analysis (Fig. 1). Fig. 1PRISMA flowchart illustrating the study selection process PRISMA flowchart illustrating the study selection process Characteristics of included studies Table 1 summarizes the key characteristics of the eleven studies [5–8, 11–17]included in our systematic review and meta-analysis, which comprise a total of 1810 cases and were published between 1992 and 2023. Notably, two studies had Kocher as the first author, while the other nine were authored by different researchers. The included studies featured two prospective and nine retrospective designs, with sample sizes ranging from 48 to 439 pediatric cases. Table 1Characteristics of the studies included in the analysis quality of included studiesAuthorYearStudy designAgeSample sizeSATSHPrimary clinical differential indicatorsDel Beccaro et al.1992RetrospectiveRange:2.5w-17y13238941)History of fever:≥ 38.5℃;2)Erythrocyte sedimentation rate:>20 mm/hTaylor et al.1994RetrospectiveMean:5.4y439214181)History of fever:≥ 38.0℃;2)Erythrocyte sedimentation rate:>20 mm/hEich et al.1999RetrospectiveRange:1 m-12.5y728641)History of fever:≥ 38.0℃;2)Erythrocyte sedimentation rate:>10 mm/h;3)C-reactive protein:>10 mg/lKocher et al.1999RetrospectiveMean: 6 ± 4.2y16882861)History of fever:≥38.5℃;2)Non-weight-bearing;3)Erythrocyte sedimentation rate:> 40 mm/h;4)Serum white blood-cell count:> 12,000 mm/3Jung et al.2003RetrospectiveRange:1 m–15y12427971)History of fever:≥ 37.0℃;2)Erythrocyte sedimentation rate:> 20 mm/h;3)Serum white blood-cell count:>11,000 mL;4)C-reactive protein:>1 mg/dlKocher et al.2004ProspectiveMean:5.7 ± 3.6y154511031)History of fever:≥ 38.5℃;2)Non-weight-bearing;3)Erythrocyte sedimentation rate:> 40 mm/h;4)Serum white blood-cell count:>12,000 mm/3Luhmann et al.2004RetrospectiveMean:63.4 ± 45.7 m165471181)History of fever:≥ 38.5℃;2)Non-weight-bearing;3)Erythrocyte sedimentation rate:>40 mm/h;4)Serum white blood-cell count:>12,000 mm/3Caird et al.2006ProspectiveMean: 5.5y4834141)Non-weight-bearing;2)Erythrocyte sedimentation rate:> 40 mm/h;3)Serum white blood-cell count:>40 mm/h;4)C-reactive protein:>20 mg/lSultan et al.2010RetrospectiveRange:1-12y965911)History of fever:≥ 38.5℃;2)Non-weight-bearing; 3)Erythrocyte sedimentation rate:>40 mm/h;4)Serum white blood-cell count:>12,000 mm/3;5)C-reactive protein:>20 mg/lSinghal et al.2011RetrospectiveMean:5.3y311292821)History of fever:≥ 38.5℃;2)Non-weight-bearing;3)Serum white blood-cell count:>12,000 mm/3;4)C-reactive protein:>20 mg/lOlandres et al.2023RetrospectiveMedian:8y1017941)History of fever:≥ 38.5℃;2)Non-weight-bearing;3)Erythrocyte sedimentation rate:>40 mm/h;4)Serum white blood-cell count:>12,000 mm/3;5)C-reactive protein:>20 mg/lSA: septic arthritis of the hip; TSH: transient synovitis of the hip; y: years; m: months; w: weeks Table 1Characteristics of the studies included in the analysis quality of included studiesAuthorYearStudy designAgeSample sizeSATSHPrimary clinical differential indicatorsDel Beccaro et al.1992RetrospectiveRange:2.5w-17y13238941)History of fever:≥ 38.5℃;2)Erythrocyte sedimentation rate:>20 mm/hTaylor et al.1994RetrospectiveMean:5.4y439214181)History of fever:≥ 38.0℃;2)Erythrocyte sedimentation rate:>20 mm/hEich et al.1999RetrospectiveRange:1 m-12.5y728641)History of fever:≥ 38.0℃;2)Erythrocyte sedimentation rate:>10 mm/h;3)C-reactive protein:>10 mg/lKocher et al.1999RetrospectiveMean: 6 ± 4.2y16882861)History of fever:≥38.5℃;2)Non-weight-bearing;3)Erythrocyte sedimentation rate:> 40 mm/h;4)Serum white blood-cell count:> 12,000 mm/3Jung et al.2003RetrospectiveRange:1 m–15y12427971)History of fever:≥ 37.0℃;2)Erythrocyte sedimentation rate:> 20 mm/h;3)Serum white blood-cell count:>11,000 mL;4)C-reactive protein:>1 mg/dlKocher et al.2004ProspectiveMean:5.7 ± 3.6y154511031)History of fever:≥ 38.5℃;2)Non-weight-bearing;3)Erythrocyte sedimentation rate:> 40 mm/h;4)Serum white blood-cell count:>12,000 mm/3Luhmann et al.2004RetrospectiveMean:63.4 ± 45.7 m165471181)History of fever:≥ 38.5℃;2)Non-weight-bearing;3)Erythrocyte sedimentation rate:>40 mm/h;4)Serum white blood-cell count:>12,000 mm/3Caird et al.2006ProspectiveMean: 5.5y4834141)Non-weight-bearing;2)Erythrocyte sedimentation rate:> 40 mm/h;3)Serum white blood-cell count:>40 mm/h;4)C-reactive protein:>20 mg/lSultan et al.2010RetrospectiveRange:1-12y965911)History of fever:≥ 38.5℃;2)Non-weight-bearing; 3)Erythrocyte sedimentation rate:>40 mm/h;4)Serum white blood-cell count:>12,000 mm/3;5)C-reactive protein:>20 mg/lSinghal et al.2011RetrospectiveMean:5.3y311292821)History of fever:≥ 38.5℃;2)Non-weight-bearing;3)Serum white blood-cell count:>12,000 mm/3;4)C-reactive protein:>20 mg/lOlandres et al.2023RetrospectiveMedian:8y1017941)History of fever:≥ 38.5℃;2)Non-weight-bearing;3)Erythrocyte sedimentation rate:>40 mm/h;4)Serum white blood-cell count:>12,000 mm/3;5)C-reactive protein:>20 mg/lSA: septic arthritis of the hip; TSH: transient synovitis of the hip; y: years; m: months; w: weeks Characteristics of the studies included in the analysis quality of included studies SA: septic arthritis of the hip; TSH: transient synovitis of the hip; y: years; m: months; w: weeks Quality of included studies The quality of the eleven studies was assessed using the QUADAS-2 tool in Review Manager 5.3 (Fig. 2), revealing that two studies (18%) included consecutive patients without inappropriate exclusions after initial recruitment, while the remaining nine did not clearly describe their enrollment methods, introducing potential biases in patient selection. Additionally, in four studies (36%), the risk of bias related to the flow and timing of the index test and reference standard was unclear due to the lack of definitive reporting on successful assessments for all included patients. Overall, most studies demonstrated minimal risk of bias concerning the applicability of reference standards, index tests, and patient selection. Fig. 2Summary of QUADAS-2 results: risk of bias graph (A) and risk of bias summary (B) for the included studies Summary of QUADAS-2 results: risk of bias graph (A) and risk of bias summary (B) for the included studies Main findings of the meta-analysis Table 2 summarizes the key characteristics of the six studies [5–8, 11, 12] included in our meta-analysis. The age range was between 5 and 8 years. In the clinical algorithm, a history of fever was reported in five studies, non-weight-bearing status in six, erythrocyte sedimentation rate in five, serum white blood cell count in six, and C-reactive protein in three. Table 2Characteristics of the included studies in the meta-analysis history of feverAuthorYearStudy designAgeSample sizeSATSHClinical indicatorsAdjusted odds ratio95%CIKocher et al.1999RetrospectiveMean:6 ± 4.2y1688286History of fever38.610.8–137.0Non-weight-bearing24.35.6–85.2Erythrocyte sedimentation rate25.96.5-112.6Serum white blood-cell count14.44.0-51.5Kocher et al.2004ProspectiveMean:5.7 ± 3.6y15451103History of fever4.41.8–10.4Non-weight-bearing5.92.2–16.1Erythrocyte sedimentation rate4.51.8–10.9Serum white blood-cell count4.11.7–10.0Luhmann et al.2004RetrospectiveMean:63.4 ± 45.7 m16547118History of fever3.31.3–8.6Non-weight-bearing0.50.2–1.5Erythrocyte sedimentation rate2.30.9–5.9Serum white blood-cell count3.51.5–8.4Caird et al.2006ProspectiveMean:5.5y483414Non-weight-bearing3.2140.52–23.2Erythrocyte sedimentation rate7.0411.52–51.84Serum white blood-cell count1.8040.414–8.59C-reactive protein14.4963.240-64.862Singhal et al.2011RetrospectiveMean:5.3y31129282History of fever2.60.4–17.5Non-weight-bearing14.63.7–58.7Serum white blood-cell count1.20.3–4.7C-reactive protein30.67.8–120.3Olandres et al.2023RetrospectiveMedian:8y101794History of fever5.081.12–23.09Non-weight-bearing7.960.59–107.27Erythrocyte sedimentation rate1.041.01–1.08Serum white blood-cell count1.140.82–1.57C-reactive protein1.020.99–1.06SA: septic arthritis of the hip; TSH: transient synovitis of the hip. History of fever ≥ 38.5℃, Erythrocyte sedimentation rate > 40 mm/h, Serum white blood-cell count > 12,000 mm/3, C-reactive protein > 20 mg/l Table 2Characteristics of the included studies in the meta-analysis history of feverAuthorYearStudy designAgeSample sizeSATSHClinical indicatorsAdjusted odds ratio95%CIKocher et al.1999RetrospectiveMean:6 ± 4.2y1688286History of fever38.610.8–137.0Non-weight-bearing24.35.6–85.2Erythrocyte sedimentation rate25.96.5-112.6Serum white blood-cell count14.44.0-51.5Kocher et al.2004ProspectiveMean:5.7 ± 3.6y15451103History of fever4.41.8–10.4Non-weight-bearing5.92.2–16.1Erythrocyte sedimentation rate4.51.8–10.9Serum white blood-cell count4.11.7–10.0Luhmann et al.2004RetrospectiveMean:63.4 ± 45.7 m16547118History of fever3.31.3–8.6Non-weight-bearing0.50.2–1.5Erythrocyte sedimentation rate2.30.9–5.9Serum white blood-cell count3.51.5–8.4Caird et al.2006ProspectiveMean:5.5y483414Non-weight-bearing3.2140.52–23.2Erythrocyte sedimentation rate7.0411.52–51.84Serum white blood-cell count1.8040.414–8.59C-reactive protein14.4963.240-64.862Singhal et al.2011RetrospectiveMean:5.3y31129282History of fever2.60.4–17.5Non-weight-bearing14.63.7–58.7Serum white blood-cell count1.20.3–4.7C-reactive protein30.67.8–120.3Olandres et al.2023RetrospectiveMedian:8y101794History of fever5.081.12–23.09Non-weight-bearing7.960.59–107.27Erythrocyte sedimentation rate1.041.01–1.08Serum white blood-cell count1.140.82–1.57C-reactive protein1.020.99–1.06SA: septic arthritis of the hip; TSH: transient synovitis of the hip. History of fever ≥ 38.5℃, Erythrocyte sedimentation rate > 40 mm/h, Serum white blood-cell count > 12,000 mm/3, C-reactive protein > 20 mg/l Characteristics of the included studies in the meta-analysis history of fever SA: septic arthritis of the hip; TSH: transient synovitis of the hip. History of fever ≥ 38.5℃, Erythrocyte sedimentation rate > 40 mm/h, Serum white blood-cell count > 12,000 mm/3, C-reactive protein > 20 mg/l History of fever The forest plot for the association between history of fever and distinguishing septic arthritis and pediatric transient synovitis of the hip is shown in Fig. 3. The pooled adjusted odds ratio illustrated that history of fever was a remarkable risk factor (OR = 6.04, 95% CI = 2.44–14.97, P = 0.000; I2 = 63.7%, P = 0.026). Deeks’ funnel plot analysis indicated evidence of publication bias. Fig. 3Forest plot of history of fever between SA and TSH groups Forest plot of history of fever between SA and TSH groups Non-weight-bearing The forest plot for the association between non-weight-bearing and distinguishing septic arthritis and pediatric transient synovitis of the hip is shown in Fig. 4. The pooled adjusted odds ratio illustrated that non-weight-bearing was a remarkable risk factor (OR = 5.23, 95% CI = 1.38–19.75, P = 0.015; I2 = 81.7%, P = 0.000). Deeks’ funnel plot analysis indicated evidence of publication bias. Fig. 4Forest plot of non-weight-bearing between SA and TSH groups Forest plot of non-weight-bearing between SA and TSH groups Erythrocyte sedimentation rate The forest plot for the association between erythrocyte sedimentation rate and distinguishing septic arthritis and pediatric transient synovitis of the hip is shown in Fig. 5. The pooled adjusted odds ratio illustrated that erythrocyte sedimentation rate was a remarkable risk factor (OR = 3.98, 95% CI = 1.29–12.30, P = 0.017; I2 = 89.1%, P = 0.000). Deeks’ funnel plot analysis indicated evidence of publication bias. Fig. 5Forest plot of erythrocyte sedimentation rate between SA and TSH groups Forest plot of erythrocyte sedimentation rate between SA and TSH groups Serum white blood-cell count The forest plot for the association between serum white blood-cell count and distinguishing septic arthritis and pediatric transient synovitis of the hip is shown in Fig. 6. The pooled adjusted odds ratio illustrated that serum white blood-cell count was a remarkable risk factor (OR = 2.73, 95% CI = 1.23–6.03, P = 0.013; I2 = 78.5%, P = 0.000). Deeks’ funnel plot analysis indicated evidence of publication bias. Fig. 6Forest plot of serum white blood-cell count between SA and TSH groups Forest plot of serum white blood-cell count between SA and TSH groups C-reactive protein The forest plot for the association between C-reactive protein and distinguishing septic arthritis and pediatric transient synovitis of the hip is shown in Fig. 7. The pooled adjusted odds ratio indicated that C-reactive protein was not a significant risk factor (OR = 7.12, 95% CI = 0.59–85.70, P = 0.122; I2 = 94.4%, P = 0.000). Deeks’ funnel plot analysis indicated evidence of publication bias. Fig. 7Forest plot of c-reactive protein between SA and TSH groups Forest plot of c-reactive protein between SA and TSH groups Overview of studies not included in the meta-analysis The association between history of fever and the differentiation of septic arthritis and pediatric transient synovitis of the hip reveals that history of fever ≥ 38.5 °C is a significant risk factor. However, two studies [14, 15] indicated that history of fever ≥ 38.0 °C is also a notable risk factor, while one study [16] reported that history of fever ≥ 37.0 °C remains a significant risk factor. Erythrocyte sedimentation rate plays a crucial role in distinguishing between septic arthritis and pediatric transient synovitis of the hip. Erythrocyte sedimentation rate exceeding 40 mm/h is identified as a significant risk factor. Additionally, three studies [13, 14, 16] have found that erythrocyte sedimentation rate greater than 20 mm/h is also noteworthy, while one study [15] identified Erythrocyte sedimentation rate above 10 mm/h as remaining significant. C-reactive protein levels exceeding 20 mg/L are crucial for differentiating septic arthritis from pediatric transient synovitis of the hip. Additionally, two studies [15, 16] have identified C-reactive protein levels above 10 mg/L as important indicators. Discussion Key findings To our knowledge, no meta-analysis has reported on the correlation of various clinical indicators in differentiating septic arthritis from pediatric transient synovitis of the hip. Our review analyzed eleven studies that evaluated the predictive value of clinical indicators for this distinction. The quality assessment of these studies revealed varied results, with most being classified as having a moderate to low risk of bias. Some analyses exhibited heterogeneity, likely due to differences in patient demographics. Despite these variations, this meta-analysis offers important insights into the potential utility of clinical indicators in differentiating septic arthritis from pediatric transient synovitis of the hip. The findings indicate that factors such as a history of fever, non-weight-bearing status, erythrocyte sedimentation rate, and serum white blood cell count were significant in making this distinction. Comparisons with the existing evidence This study identified several clinical indicators—specifically, history of fever, non-weight-bearing status, erythrocyte sedimentation rate, and serum white blood cell count—as significant factors in distinguishing septic arthritis from pediatric transient synovitis of the hip. These findings are consistent with previous research that emphasizes the relevance of these indicators in clinical practice [5, 11]. However, it is essential to recognize that the age range of children included in the original studies contributing to this meta-analysis was between 5 and 8 years. While this age group is typical for conditions such as transient synovitis [18], there are important limitations when considering the applicability of these findings to younger populations, particularly neonates and infants. These younger age groups often present with distinct clinical and laboratory features that may not align with the predictors established in older children. Numerous studies have underscored that diagnostic predictors for conditions like septic arthritis and transient synovitis of the hip are closely linked to the patient’s age [19, 20]. For instance, in neonates, common laboratory parameters associated with infection, such as erythrocyte sedimentation rate, and serum white blood cell count, may not consistently reflect an infectious process [21]. Furthermore, neonates may exhibit subtle clinical signs, often limited to pseudoparalysis of the affected limb, which complicates the diagnostic process [22]. This scenario highlights the critical importance of considering age-specific clinical presentations when diagnosing these conditions in younger patients. In infants, the diagnostic challenges are further compounded by the frequent absence of fever, a classic symptom that clinicians typically rely on when assessing for infections. Additionally, infants’ inability to ambulate makes it difficult to evaluate symptoms related to weight-bearing or joint movement [23]. Consequently, these children may not exhibit the more overt signs of joint inflammation commonly observed in older children, such as limping or refusal to bear weight [24]. These considerations underscore the necessity for heightened clinical vigilance and the implementation of age-specific diagnostic approaches when evaluating young patients. In contrast, this study indicated that C-reactive protein was not identified as a significant risk factor for distinguishing between septic arthritis and transient synovitis. This finding diverges from existing literature, which asserts that C-reactive protein plays a valuable role in the diagnostic process [6, 12]. The discrepancies in findings may arise from the limited number of studies included in this analysis, as well as variations in the quantification methods for C-reactive protein employed across different investigations, which could contribute to inconsistencies in results [25]. C-reactive protein is a widely used inflammatory marker in clinical practice, but it is important to note that its levels can be influenced by a variety of factors beyond the presence of infection [26]. These include the patient’s age, the time elapsed since symptom onset, the timing of presentation to healthcare services, as well as the general health and condition of the patient [27]. In particular, C-reactive protein may vary significantly depending on how long after the onset of symptoms the patient presents for care, and whether the patient has already started any form of treatment, such as antibiotics or anti-inflammatory medications [27]. In the early stages of an infection or inflammatory condition, C-reactive protein might be elevated but could normalize rapidly with treatment, making it less reliable as a marker for diagnosis or severity if measured too late in the course of illness. Measuring C-reactive protein at initial presentation, before the initiation of any treatment, would likely provide the most accurate representation of the acute inflammatory response. However, the role of C-reactive protein remains ambiguous and merits further investigation. Strength and limitations The present study has several strengths. First, this systematic review and meta-analysis evaluate the correlation of various clinical indicators in differentiating septic arthritis from pediatric transient synovitis of the hip. By consolidating existing research, this study provides a foundational understanding of this medical phenomenon. Second, these clinical indicators may aid clinicians in early treatment planning, potentially enhancing patient outcomes. Based on readily accessible data from clinical history, physical examinations, and routine complete blood counts, they offer a cost-effective option for early assessment. Third, clinical indicators that can distinguish transient synovitis from septic arthritis in children—conditions with differing prognoses—can guide decisions regarding the necessity for advanced treatment. Several limitations inherent to this systematic review and meta-analysis require attention. First, the impact of medication use and the lack of uniformity in parameter values for clinical indicators may influence the effectiveness of clinical indicators across the included studies. Second, there is a limited number of studies investigating the role of clinical indicators in differentiating between septic arthritis and pediatric transient synovitis of the hip, with only two being prospective in design. To fortify these findings, additional research employing diverse study designs and larger sample sizes is necessary. Third, our review was restricted to studies published in English, which may have resulted in the omission of relevant research conducted in other languages, thereby introducing potential language bias into our conclusions. The implication of the findings The implications of this study are significant for both clinical practice and future research. Upcoming investigations must focus on validating the accuracy of reference standards used to differentiate between septic arthritis and transient synovitis in children. Future studies should also aim to incorporate larger sample sizes to achieve a more comprehensive understanding of these conditions. Additionally, conducting larger prospective cohort studies is recommended to determine which combinations of clinical indicators provide improved sensitivity in diagnosing these disorders. Conclusion The clinical indicators involving a history of fever, non-weight-bearing status, erythrocyte sedimentation rate, and serum white blood cell count have been identified as cost-effective routine tests with potential value in differentiating septic arthritis from pediatric transient synovitis of the hip. To enhance the reliability of these findings, further prospective studies are essential.